Capsugel® - A Lonza Company
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

28

Sep 2020

AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease

AVROBIO Inc a leading clinicalstage gene therapy company with a mission to free people from a lifetime of genetic disease announced that the European Commission EC has granted orphan drug designation for AVRRD the companys investigational gene therapy for the treatment of Gaucher disease

26

Sep 2020

Vivet Therapeutics and Pfizer Inc. Sign Agreement to Manufacture Investigational Gene Therapy Product Developed by Vivet for Wilson's Disease

Vivet Therapeutics Vivet a privately held gene therapy biotechnology company dedicated to developing treatments for severe inherited liver diseases and Pfizer Inc announced that have signed a manufacturing agreement under which Pfizer will supply the necessary material for a phase clinical trial t...

25

Sep 2020

AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration

AbCellera and IGM Biosciences Inc announced today that they have entered into a multiyear multitarget strategic research collaboration and license agreement to facilitate the discovery and development of novel IgM antibodies

25

Sep 2020

Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic

Lumen Bioscience a clinicalstage biopharmaceutical company developing biologic drugs for highly prevalent diseases and the US Army Medical Research and Development Command USAMRDC operating through the Medical Technology Enterprise Consortium MTEC announced an agreement to develop a rapid scalable a...

press releasesRead more...

28

Sep 2020

60 years of Packaging Excellence - Syntegon’s Schiedam site celebrates anniversary and long heritage

Syntegon Technologys Schiedam site is celebrating over half a century of market presence In October the companys Dutch site turns Today a marketleading provider of horizontal flow wrappers infeed and distribution systems the current Syntegon Packaging Technology BV took up business as Tevopharm

28

Sep 2020

Etihad Cargo Reinforces Pharmaceutical Shipment Expertise With PharmaLife Launch

Etihad Cargo the cargo and logistics arm of Etihad Aviation Group has reinforced its pharmaceutical logistics expertise with the launch of PharmaLife a specialised pharma and healthcare product which replaces the carriers TempCheck productb

28

Sep 2020

FDA Grants IND Approval for Phase II Clinical Trial Using Stemedica's itMSC Therapy for COVID-19 Patients

Stemedica Cell Technologies Inc has received US Food and Drug Administration FDA Investigational New Drug IND approval for A Phase II MultiCenter Randomized DoubleBlind PlaceboControlled Study to Assess the Safety Tolerability and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells...

26

Sep 2020

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

GlaxoSmithKline plc announced the US Food and Drug Administration FDA has approved Nucala mepolizumab for the treatment of adult and pediatric patients aged years and older with Hypereosinophilic Syndrome HES for six months without an identifiable nonhematologic secondary cause

EventsRead more...

28 - 30

Sep 2020

Brain and Neurological Disorders

Iris Scientific Group
Rome

29 - 01

Sep 2020

Pharma CI USA

Pharma CI Conference
Virtual

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Life Sciences - Clinical, TNT Asia

    Director

    Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical Recent revisions to the pharmaceutical industrys regulatory laws as well as improved patent laws in countries such as Japan China and...
  • Techno Trends

    FDA Grants Breakthrough Therapy Designation to Fennec PEDMARK™

    The US Food and Drug Administration FDA awarded breakthrough therapy designation to Fennec Pharmaceuticals PEDMARK a unique formulation of sodium thiosulfate for prevention of cisplatinrelated ototoxicity in pediatric patients with standardrisk hepatoblastomaSRHB The Fast Track designation will facilitate development and accelerate the review of drugs to treat seri...

  • White Papers

    Crippled by Cost? CMO Quo Vadis

    Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma com...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...